About BioGnost
BioGnost is a Healthcare company based in Zagreb (Croatia) founded in 1990. Immunohematologic and immunochromatographic diagnostic devices are manufactured and marketed. Its website biognost.com draws about 15 thousand monthly visits. BioGnost offers products and services including Histology Staining Reagents, Rapid Diagnostic Tests, and Immunohematology Products. Its focus areas include Diversified Diagnostics. Its legal entity is BIOGNOST D.O.O.
Company details
BioGnost was established in 1990 in Zagreb, Croatia, within the in vitro diagnostics sector. Immunohematologic and immunochromatographic devices are produced and distributed by the company, alongside laboratory kits, medical equipment, and products for microbiology, microscopy, and transfusiology. Lateral flow tests covering tumor markers, cardiac indicators, infectious diseases, womens health, urine parameters, and drug detection are included in the portfolio. Items are sold under brands such as AbuGnost, GraviGnost, and OvuGnost.
- Headquarters Zagreb, Croatia
- SectorsHealthcare
- Email••••••••
- Website biognost.com
- Social LinkedIn Facebook Instagram
- Legal Name Biognost D.O.O.
- Annual Revenue$5.71 M (USD)16as on Dec 31, 2020
- Net Profit$187.82 K (USD)7as on Dec 31, 2020
- Latest Funding Round$32.3 (USD), Grant
Feb 2017
- Investors
Products & Services of BioGnost
BioGnost offers a comprehensive portfolio of products and services, including Histology Staining Reagents, Rapid Diagnostic Tests, and Immunohematology Products.
Reagents for staining tissue samples in histopathology laboratories.
Tests for detecting infectious diseases quickly and accurately.
Kits for immunohematology diagnoses in transfusiology.
Funding Insights of BioGnost
- Total Rounds 1
- Last Round Grant — $32
- First Round $32
(Feb 2017)
- Investors Count 1
All 1 funding rounds of BioGnost with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Feb 2017 | $32 | Grant | – | – |
1 investors in total: 1 institutional.
Investors in BioGnost
BioGnost has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include European Union.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Government entites focused on freedom, democracy, equality and the rule of law, promoting peace and stability | 1958 | europa.eu | Brussels, Belgium |
Investor details for BioGnost
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Timeline of BioGnost
2 dated milestones of BioGnost across 27 years, from founding to its latest funding, stage changes and deals.
- Founded BioGnost is founded.
- Funding First funding round of $32.
Web traffic of BioGnost
The website of BioGnost (biognost.com) receives about 14.7K visits a month.
- Monthly visits14.7K
▲ 6.7% vs previous month
Websites whose visitors overlap most with BioGnost. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
dalynn.com | dalynn.com | 100% | #1,816,829 | – | |
stainsfile.com | stainsfile.com | 89% | #1,090,107 | – | |
| himedialabs.com | 78% | 284.7K | #167,428 | View details | |
newcomersupply.com | newcomersupply.com | 78% | #2,729,934 | – | |
| hardydiagnostics.com | 78% | #583,854 | View details | ||
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
All 11 similar websites and full traffic analytics for BioGnost
The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.
- 11 similar websites
- Audience overlap
- Engagement analytics
- Traffic by brand
Verified entity values are shown only after access is granted.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about BioGnost
BioGnost was founded in 1990 and raised its 1st funding round 27 years after it was founded.
BioGnost is headquartered in Zagreb, Croatia.
Annual revenue of BioGnost is $5.71M as on Dec 31, 2020.
BioGnost was established in 1990 in Zagreb, Croatia, within the in vitro diagnostics sector. Immunohematologic and immunochromatographic devices are produced and distributed by the company, alongside laboratory kits, medical equipment, and products for microbiology, microscopy, and transfusiology. Lateral flow tests covering tumor markers, cardiac indicators, infectious diseases, womens health, urine parameters, and drug detection are included in the portfolio. Items are sold under brands such as AbuGnost, GraviGnost, and OvuGnost.
BioGnost offers Histology Staining Reagents, Rapid Diagnostic Tests, and Immunohematology Products.
BioGnost has 1 investor. Key investors include European Union.
BioGnost operates through Biognost D.O.O..